Based on the function of Id4, OLIG1, and OLIG2 during normal development, our data suggest that Id4 and potentially other genes such as Fabp7 and Ptprz1 might account for the formation of distinct glioma subtypes during oncogenic progression. This evidence concerns the gene OLIG2 and central nervous system cancer.